RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Testosterone - TTS /LTS
Currently, LTS has two matrix formulation under development varying in their manufacturing process More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Testosterone Replacement Therapy Market Forecast
Sep 2010 - $15,200
Pipeline and Commercial Insight: Testosterone Replacement Therapy - Topical formulations drive market growth
Sep 2010 - 29 pages - $15,200
Metabolic and Endocrinology Pipeline Databook - November 2011
Nov 2011 - 7 pages - $3,835
Versartis, Inc. – Product Pipeline Review – H2 2011
Oct 2011 - 41 pages - $500
FDA Approves Zytiga (Abiraterone Acetate) for the Second-Line Treatment of Metastatic Castration-Resistant Prostate Cancer
May 2011 - 5 pages - $500
Post ADA Diabetes Treatment Market Assessment
Jun 2008 - $2,500
Tercica Inc: Premium Company Profile
Dec 2007 - 56 pages - $495
Male Hypogonadism - Pipeline Review, H2 2011
Sep 2011 - 79 pages - $500
FDA Approves Xarelto (Rivaroxaban) - The First New Oral Anticoagulant Approved to Prevent VTE in Joint Replacement Surgeries in the US
Jul 2011 - 6 pages - $500
Hormone Replacement Therapy For Menopausal Symptoms Market Forecast
Sep 2010 - $15,200
More Related Market Research Reports >>>

Your selection

Therapeutic target
Endocrinology del
Testosterone replacement del
Development phase
Preclinical del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us